Bloom Energy (NYSE: BE), a global player in power solutions, and Brookfield (BAM.TO, BAM) announced a US$5 billion strategic partnership to implement a "reimagined future" for AI infrastructure. "This partnership marks the first phase of a joint vision to build AI factories capable of meeting the growing compute and power demands of artificial intelligence," a statement said. Among highlights, Bloom Energy will become the preferred onsite power provider for Brookfield's global AI factories. The partnership marks Brookfield's first investment through its dedicated AI Infrastructure strategy.
Separately, Brookfield and Oaktree agreed on a proposed transaction whereby Brookfield will acquire the approximately 26% interest in Oaktree that it does not already own. Upon completion of the proposed transaction, Brookfield will own 100% of Oaktree, a global credit manager, further strengthening Brookfield's credit platform. Under the proposed terms of the transaction, Brookfield Asset Management and Brookfield Corporation will acquire all of the remaining common equity interests in the Oaktree business for total consideration of approximately $3 billion. Of the $3 billion price, BAM and BN will fund approximately $1.6 billion and $1.4 billion, respectively, reflecting their proportional ownership of Oaktree today. The proposed transaction is expected to close in the first quarter of 2026, subject to regulatory approvals and customary closing conditions, and is expected to be accretive to both BAM and BN.
Meanwhile, IsoEnergy (NYSE American: ISOU and TSX: ISO) and Toro Energy (ASX: TOE) entered into a scheme implementation deed that saw IsoEnergy agree to acquire all of the issued and outstanding ordinary shares of Toro by way of a scheme of arrangement under Australia's Corporations Act 2001, subject to the satisfaction of various conditions. Toro owns 100% of the Wiluna Uranium Project, located 30km south of the town of Wiluna in the northern goldfields of Western Australia.
Under the terms of the transaction, Toro shareholders will receive 0.036 of a common share of IsoEnergy for each Toro Share held on the scheme record date. Existing shareholders of IsoEnergy and Toro will own approximately 92.9% and 7.1% on a fully-diluted in-the-money basis, respectively, of the outstanding ISO Shares upon implementation of the transaction. The Exchange Ratio implies consideration of A$0.584 per Toro share, representing: a 79.7% premium to the last traded price on the ASX of A$0.325 per Toro share, on October 10, 2025; and a 92.2% premium to Toro's 20-day volume weighted average price on the ASX as at October 10, 2025. The implied fully-diluted in-the-money equity value of the transaction is equal to approximately A$75.0million (C$68.1million).
Elsewherem Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global player in medicinal cannabis, announced plans to expand its medical cannabis operations into Panama. In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Global Inc., whose members have experience in the distribution of medical devices since 2014. Together, Tilray and Top Tech, through their joint venture company, Solana Life Group, have received a medical cannabis license issued by the National Directorate of Pharmacy and Drugs in Panama authorizing the cultivation, manufacturing, import, export, distribution and sale of medical cannabis in Panama.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.